<DOC>
	<DOC>NCT01257126</DOC>
	<brief_summary>This is a local, phase IV, open-label, randomized, head to head study of children aged 3 to 7 years. The objective of the study is to compare the efficacy of a single dose of both diclofenac potassium and nimesulide in the reduction of fever and pain secondary to upper respiratory tract infection.</brief_summary>
	<brief_title>Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Nimesulide</mesh_term>
	<criteria>Children who present community acquired, noncomplicated, upper respiratory tract infection: rhinosinusitis, pharyngitis, tonsillitis, ear infection or the combination of these. Child must present axillary temperature ≥ 37.5°C. Prior history of allergic reaction to the components of the study medication. Use of any NSAID or pharmacologic agent in the 24 hours prior to visit 1. Subjects who, in the opinion of the investigator, have developed, or are at risk of developing, a complicated infection and are not suitable subjects for the purposes of the study. Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Upper respiratory tract infections</keyword>
	<keyword>diclofenac potassium</keyword>
	<keyword>nimesulide</keyword>
	<keyword>fever</keyword>
	<keyword>pain</keyword>
</DOC>